Abstract
The long-term follow-up analysis of the SWOG0816 trial, presented by Stephens et al1 in this issue of Blood, reminds us that long-term retrospect is needed to understand studies of a highly curable disease of the young.
Cite
CITATION STYLE
APA
Hutchings, M. (2019, October 10). PET-adapted treatment of Hodgkin lymphoma. Blood. American Society of Hematology. https://doi.org/10.1182/blood.2019002420
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free